Onsdag 28 Oktober | 21:18:48 Europe / Stockholm
Svenska | English

All ägardata du vill ha finns i Holdings!

Guard Therapeutics: Intervju - Positivt utfall i säkerhetsutvärdering

2025-05-28 15:45:00

I en intervju berättar Guards Therapeutics vd Tobias Agervald och chef för klinisk verksamhet, Sara Thuresson, om det positiva utfallet i den säkerhetsutvärdering som presenterades under tisdagen. Det pratas även om hur patientrekryteringen till studien fortskrider samt bolagets tankar kring affärsutveckling.

Hitta intervjun på DNB Carnegie Play: https://youtu.be/EKks4OKw28Q
Detta är uppdragsanalys från DNB Carnegie. Läs mer här: https://www.carnegie.se/en/commissioned-research/

Information
This is a press release from DNB Carnegie. For information about DNB Carnegie commissioned research, see https://www.carnegie.se/en/commissioned-research/, or contact our commissioned research team at cr@carnegie.se.

About Us
DNB Carnegie is the leading and independent Nordic investment and private bank. Our operations within Corporate Finance, Securities and Research, Private Banking and Wealth Management are among the market leaders within their respective sectors. Together, they build an unbeatable combination of integrated knowledge, guiding our clients towards better business. DNB Carnegie operates in six countries and has more than 800 employees.

Källa MFN
Enter your email address and you will get a mail for verification you subscription to content on this page and filter


Select the time zone location for site wide time

Europe
London
Oslo
Stockholm
Helsinki

America
New York / Eastern
Chicago / Central
Los Angeles / Western

Företag
Pressmeddelanden